PB1813: EFFICACY OF AZACITIDINE AND VENETOCLAX IN AML PATIENTS MAY BE LIMITED BY INTERACTION WITH POSACONAZOLE AND LACK OF STANDARDISED TREATMENT PROTOCOL. REAL WORLD DATA FROM 3 MAJOR CENTRES IN SINGAPORE.

التفاصيل البيبلوغرافية
العنوان:	PB1813: EFFICACY OF AZACITIDINE AND VENETOCLAX IN AML PATIENTS MAY BE LIMITED BY INTERACTION WITH POSACONAZOLE AND LACK OF STANDARDISED TREATMENT PROTOCOL. REAL WORLD DATA FROM 3 MAJOR CENTRES IN SINGAPORE.
المؤلفون:	D. Christopher, N. A. Abdul Halim, C. A. Gallardo, G. H. Lim, W. Y. Jen, C. Y. Lin, E. F. Bingwen, M. Ooi, Y. L. Chee, V. S. Sampath, G. C. Wong
المصدر:	HemaSphere, Vol 6, Pp 1693-1694 (2022)
بيانات النشر:	Wiley, 2022.
سنة النشر:	2022
المجموعة:	LCC:Diseases of the blood and blood-forming organs
مصطلحات موضوعية:	Diseases of the blood and blood-forming organs, RC633-647.5
نوع الوثيقة:	article
وصف الملف:	electronic resource
اللغة:	English
تدمد:	2572-9241
Relation:	http://journals.lww.com/10.1097/01.HS9.0000850104.80221.19; https://doaj.org/toc/2572-9241
DOI:	10.1097/01.HS9.0000850104.80221.19
URL الوصول:	https://doaj.org/article/570302f24d3947329a86ab67a9b83025
رقم الأكسشن:	edsdoj.570302f24d3947329a86ab67a9b83025
قاعدة البيانات:	Directory of Open Access Journals

الوصف
تدمد:	25729241
DOI:	10.1097/01.HS9.0000850104.80221.19